Search Results for "Subsys"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Subsys. Results 1 to 3 of 3 total matches.
See also: fentanyl
Fentanyl Sublingual Spray (Subsys) for Breakthrough Cancer Pain
The Medical Letter on Drugs and Therapeutics • May 14, 2012 (Issue 1390)
Fentanyl Sublingual Spray (Subsys) for Breakthrough Cancer Pain ...
The FDA has approved a sublingual spray formulation of
fentanyl (Subsys – Insys) for management of breakthrough
pain in adult cancer patients who are receiving
and are tolerant to opioid therapy (taking ≥60 mg/day of
oral morphine or the equivalent). Fentanyl is already
available in the US for intravenous, intrathecal, epidural,
transdermal and transmucosal use.
Comparison Table: Some Oral/Transdermal Opioid Analgesics (online only)
The Medical Letter on Drugs and Therapeutics • Dec 12, 2022 (Issue 1665)
for opioid-naive patients
Actiq, Fentora, Lazanda, and Subsys are indicated only for
breakthrough pain ...
View the Comparison Table: Some Oral/Transdermal Opioid Analgesics
Opioids for Pain
The Medical Letter on Drugs and Therapeutics • Dec 12, 2022 (Issue 1665)
Not recommended for opioid-naive patients
Actiq, Fentora, Lazanda, and Subsys are
indicated only ...
A new CDC guideline for prescribing opioids for pain
recently became available. Nonopioid drugs for pain
were reviewed in a previous issue.